Skip to main content

Endoscopic ultrasonography guided cutting scar of esophageal stricture after endoscopic injection sclerotherapy



To investigate efficacy and safety of endoscopic ultrasonography (EUS) guiding to cut the scar of esophageal stricture after endoscopic injection sclerotherapy (EIS).


The data of 10 patients with oesophageal stricture after esophageal varices EIS in our hospital from September 1, 2021 to December 31, 2021 treated by cutting the scar guided by ultrasonic endoscopy were retrospective, and the efficacy was evaluated.


The dysphagia was obviously relieved in 9 patients during follow-up, and 1 patient suffered dysphagia again after the treatment. There was no complications of perforation, bleeding and infection among the paitents.


EUS guiding to cut the scar of esophageal stricture after EIS was safe and reliable.

Peer Review reports


Oesophageal stricture is one of the complication of EIS [1]. It is related to local inflammation, ulceration, and fibrosis caused by multiple EIS [2, 3]. The main symptom of oesophageal stricture is dysphagia. No standard treatment for oesophageal stricture after EIS is mentioned in international guidelines or consensuses [4,5,6,7]. Furthermore, patients often have a prolonged prothrombin time and thrombocytopenia, and balloon dilation for stricture complicated by EIS for oesophageal varices has poor outcomes [8]. We want to investigate efficacy and safety of EUS guiding to cut the scar of esophageal stricture after EIS in this article.



We reviewed the data of 10 patients with oesophageal stricture after EIS in our hospital from September 1, 2021 to December 31, 2021 treated by cutting the scar under EUS guidance.

Inclusion criteria

(1) According to the Stooler classification [9, 10], the degree of oesophageal stricture was grade II–VI. (2) The diameter of the oesophageal cavity was more than 2.6 mm, so an ultrasonic endoscope could pass. (3) The oesophageal stricture was not treated with surgery.

Exclusion criteria

(1) Severe coagulation disorder (prothrombin time > 17 s); (2) unstable blood pressure (systolic blood pressure < 80 mmHg or > 160 mmHg); (3) heart failure (Ejection Fraction < 50%), lung failure (PaO2/Fi O2 < 300 mmhg), or other organ failure; and (4) oesophageal malignancy.


The patients were followed up between three to six months: (1) The symptoms would be consultated once a week through the cell phone.We would record the complication (perforation, bleeding, and infection), and degree of the dysphagia of oesophageal stricture [9]. (2) The endoscopy would be performed every three months after treatment.


According to the Stooler criteria, degree of oesophageal stricture and dysphagia [9, 10]: Grade 0: There was no dietary restriction. Grade I: Soft food could be eaten smoothly, and food whose diameter is more than 13 mm could be passed. Grade II: Semi-liquid food whose diameter was between 8 and 13 mm could be passed. Grade III: Only liquid diet whose diameter was among 3 to 8 mm; Grade IV: Liquid diet with particles less than 3 mm in diameter was difficult to pass.

The relief criteria of oesophageal stricture were as follows: (1) The degree of stricture recovered to grade 0–I. (2) The body of the standard gastroscope could pass through the oesophagus without any resistance, and the diameter of the gastroscope was 1 cm. (3) There was no stricture recurrence during the 8-week follow-up [11].

The criteria for stricture recurrence were as follows: (1) The degree of stricture worsened to grade II–IV again. (2) The body of the standard gastroscope could not pass through the oesophagus without resistance.

Endoscopic treatment

First, we observed retention in the oesophageal cavity through gastroscopy (GIF-HQ290, with insertion tube diameter of 9.9 mm, the inside diameter of 2.8 mm; Olympus Medical Systems, Tokyo, Japan). If the passage of fluid and/or solid was blocked by the stricture, it was necessary to remove the residue. When the oesophageal stricture was fully exposed (Fig. 1), we used the microprobe of ultrasonic endoscope to scan the oesophageal stricture. EUS examination was performed using the microprobe (20 MHz, P2620-M, diameter of 2.6 mm; FUJIFILM, Japan) and high frequency generator (SP-900, FUJIFILM, Japan). Briefly, the procedure was performed with the patient under conscious sedation. The microprobe was inserted through the instrument channel and negotiated across the oesophageal stricture under endoscopic vision. The ultrasonography of the scar manifested as uneven hypoecho, thickening of the mucosa and/or submucosa, and unclear boundary of the oesophageal layers (Fig. 2). Thickness of scar, direction of scar, and distance to incisor were specifically recorded. If residual varices were suspected through the microprobe EUS, we used the doppler EUS to screen the residual varices. Then, we used the dualknife(Model No.KD-650L,Olympus Medical Systems, Tokyo, Japan) to cut the mucosa and submucosa along its longitudinal axis according to EUS measurements (Fig. 3). We took care not to slice the muscularis propria of the oesophagus. The electroincision requires use of incisions with the knife attached to an electrosurgical unit ERBE generator (Elektromedizin GmbH, Tübingen, Germany) with software controlled fractionated cuts in the pure cut of endoscopic submucosal dissection mode (endocut, 60w).

Figure. 1
figure 1

The esophageal stricture was obvious after EIS

Figure. 2
figure 2

Microprobe of ultrasonic endoscope scaned the scar of esophageal stricture

Figure. 3
figure 3

The scar was cut with dualknife according to the measurement by ultrasonic endoscopy


General data: Sex: There were 7 males and 3 females. Age: The average age was 47 years, ranging from 35 to 59 years. Reason for cirrhosis: There were 9 cases of hepatitis B, and 1 case of alcoholic cirrhosis; Child–Pugh classification: There were 4 cases of grade A, 4 cases of grade B, and 2 cases of grade C. Portal thrombosis: There were 3 cases of combined portal thrombosis. Hepatocellular carcinoma (HCC): There were both 2 cases complicated with HCC. Splenectomy: Three cases were treated with splenectomy. Antiviral: There were 7 cases treated with antivirals. Number of EIS: There were 1–6 times of EIS before. Number of dilation: There were 0 to 4 prior dilations for stricture. Thickness of the scar: The thickness of the stricture scar was 1.1–3.9 mm. Location of scar: The distance to the incisor of the scar ranged from 34 to 39 cm, and the directions of the scar were at one o'clock, two o'clock, nine o'clock, ten o'clock, eleven o'clock, and twelve o'clock. Degree of stricture: There were 3 cases with grade II, 5 cases with grade III, and 2 cases with grade IV (Table 1).

Table 1 The general data of the paitents

Efficacy: The dysphagia was obviously relieved in 9 patients during the follow-up of three to six months (Fig. 4). One patient suffered dysphagia again within one month after the treatment, and endoscopy found that the degree of stricture was grade III. There were no complications of perforation, bleeding or infection.

Figure. 4
figure 4

The stricture improved three months after the treatment


EIS apparently improves the control of haemorrhage from oesophageal varices and prolongs survival [12, 13], and oesophageal stricture is one of the complications of EIS, with an incidence between 2 and 10% [14]. It seriously affects the quality of life of the patient. The reasons for oesophageal stricture of EIS may be as follows: (1) The vascular endothelium is injured, and chronic inflammation and fibrous scars gradually arise after the sclerosant is injected into the varices. (2) The barrier of the oesophageal mucosa is damaged. (3) The muscularis mucosa and propria of the oesophagus may be injured, which will directly lead to scar stricture. (4) The injection is near the physiological stricture of the oesophagus. (5) The dose of sclerosant is too high. (6) The sclerosant is intensively injected at the same level of the oesophagus, and fibrous scars form at the same circumference of the oesophagus. (7) Repeated injections of sclerosant induce overlape and interlacement of the scar tissue.

The endoscopic treatment for benign oesophageal stricture includes balloon dilation, local incision, stent placement, and endoscopic steroid injection [15,16,17,18]. Balloon dilatation mainly achieves its effect through the mechanical tension of the balloon; on the other hand, it can tear the normal mucosa and/or muscularis around the oesophagus. Local incision of oesophageal strictures is reliable [18,19,20,21], and will significantly relieve dysphagia. However, We should be alert to the complication of perforation from cutting the muscularis propria of the oesophagus. Stent placement will extend the oesophageal stricture, but, complications from this are much more common, such as chest pain, reflux oesophagitis, displacement or detachment, and tissue embedded stents [21].

Ultrasonic endoscopy can clearly show the five layers of the normal oesophagus [22]. When the oesophageal inflammatory stricture scar is detected through ultrasonic endoscopy, the scar tissue is thicker than the normal mucosa, and the location and depth of the scar can be measured exactly [23, 24].

The particularity of oesophageal stricture after EIS for oesophageal varices is that most patients have risk factors such as residual varices, coagulation dysfunction, and low immunity. This article retrospectively reviews the data of 10 patients with oesophageal stricture of EIS in our hospital treated by cutting the scar through ultrasoound-guided endoscopy. The dysphagia of the stricture was obviously relieved in 9 patients during the follow-up of three to six months, while 1 patient suffered from dysphagia again within one month after the treatment. There were no complications of perforation, bleeding or infection, and some researches reported perforation rate ranges from 0 to 3.5% [25,26,27,28] in incisional treatment for esophageal stricture without EUS-guiding.The advantages of ultrasonic endoscopy-guided scar cutting are as follows: (1) It is kept away from residual varices, which avoids bleeding from varices. (2) The scar is cut according to the depth measured by ultrasonic endoscopy, which can reduce the likelihood of perforation. (3) The normal mucosa will not be torn, as can happen in balloon dilatation.

This study has several limitations, mainly related to its retrospective design, few cases, and no longer follow-up. More cases, much more longer follow-up, prospective randomized controlled trial with balloon expansion are needed to evaluate the efficacy of EUS guided cutting scar of esophageal stricture after EIS.


Ultrasound-guided endoscopy guiding to cut scars is safe and reliable. It may reduce the risk of perforation and bleeding.

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its Additional file 1].



Endoscopic ultrasonography


Endoscopic injection sclerotherapy


Hepatocellular carcinoma


Hepatitis B




  1. Evans DM, Jones DB, Cleary BK, et al. Oesophageal varices treated by sclerotherapy: a histopathological study. Gut. 1982;23(7):615–20.

    CAS  Article  Google Scholar 

  2. Ogle SJ, Kirk CJ, Bailey RJ, et al. Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices. Digestion. 1978;18(3–4):178–85.

    CAS  Article  Google Scholar 

  3. Sauerbruch T, Wirsching R, Leisner B, et al. Esophageal function after sclerotherapy of bleeding varices. Scand J Gastroenterol. 1982;17(6):745–51.

    CAS  Article  Google Scholar 

  4. Sami SS, Haboubi HN, Ang Y, et al. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67(6):1000–23.

    Article  Google Scholar 

  5. Sharma P, Kozarek R; Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010;105(2):258–73; quiz 274.

  6. Spechler SJ. American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology. 1999;117(1):229–33.

    CAS  Article  Google Scholar 

  7. Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2016;48(10):939–48.

    Article  Google Scholar 

  8. Jun Li, Liu Y, Qiao X, et al. A case of severe esophageal stricture after multiple endoscopic sclerotherapy. Chinese Journal of Endoscopy. 2018;24(9):101–5.

    Google Scholar 

  9. Duan H, Wang T, Luo Z, et al. A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study). Ann Transl Med. 2021;9(22):1700.

    CAS  Article  Google Scholar 

  10. Li Hongke Su, Yongjuan HY. Clinical effect of removable esophageal stent implantation and balloon dilation in the treatment of refractory esophageal stenosis. Clin Med. 2019;3:88–93.

    Google Scholar 

  11. Digestive Endoscopy Tunnel Technology Collaboration Group of Digestive Endoscopy Branch of Chinese Medical Association, Endoscopy Branch of Chinese Medical Doctor Association, Digestive Endoscopy Branch of Beijing Medical Association. Expert consensus on endoscopic prevention and treatment of benign and malignant esophageal strictures in China (2020, Beijing). Chin J Digest Endoscopy 2021;38(3): 173–85.

  12. Clark AW, Macdougall BR, Westaby D, et al. Prospective controlled trial of injection sclerotherapy in patient with cirrhosis and recent variceal haemorrhage. Lancet. 1980;2(8194):552–4.

    CAS  Article  Google Scholar 

  13. MacDougall BR, Westaby D, Theodossi A, et al. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results Control Trial Lancet. 1982;1(8264):124–7.

    CAS  Google Scholar 

  14. Mudawi HM, Ibrahim KB. Endoscopic variceal sclerotherapy in patiencts with Symmers periportal fibroses. Trop Doct. 2007;37(3):179–81.

    CAS  Article  Google Scholar 

  15. Poincloux L, Rouquette O, Abergel A. Endoscopic treatment of benign esophageal strictures: a literature review. Expert Rev Gastroenterol Hepatol. 2017;11(1):53–64.

    CAS  Article  Google Scholar 

  16. Hirdes MM, Siersema PD, van Boeckel PG, et al. Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy. 2012;44(7):649–54.

    CAS  Article  Google Scholar 

  17. Ramage JI Jr, Rumalla A, Baron TH, et al. A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol. 2005;100(11):2419–25.

    CAS  Article  Google Scholar 

  18. Manfredi MA, Clark SJ, Medford S, et al. Endoscopic electrocautery incisional therapy as a treatment for refractory benign pediatric esophageal strictures. J Pediatr Gastroenterol Nutr. 2018;67(4):464–8.

    Article  Google Scholar 

  19. Pih GY, Kim DH, Na HK, et al. Comparison of the efficacy and safety of endoscopic incisional therapy and balloon dilatation for esophageal anastomotic stricture. J Gastrointest Surg. 2021;25(7):1690–5.

    Article  Google Scholar 

  20. Tano T, Yoda Y, Satake H, et al. Radial incision and cutting method for refractory stricture after nonsurgical treatment of esophageal cancer. Endoscopy. 2013;45(4):316–9.

    Article  Google Scholar 

  21. Spaander MCW, van der Bogt RD, Baron TH, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021;53(7):751–62.

    Article  Google Scholar 

  22. Aibe T, Fuji T, Okita K, et al. A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography. Scand J Gastroenterol Suppl. 1986;123:6–15.

    CAS  Article  Google Scholar 

  23. Daniel P, Samanta J, Gulati A, et al. Can high-frequency mini-probe endoscopic ultrasonography predict outcome of endoscopic dilation in patients with benign esophageal strictures? Endosc Int Open. 2020;8(10):E1371–8.

    Article  Google Scholar 

  24. Rana SS, Sharma R, Kishore K, et al. High-frequency miniprobe endoscopic ultrasonography in the management of benign esophageal strictures. Ann Gastroenterol. 2020;33(1):25–9.

    PubMed  Google Scholar 

  25. Lee TH, Lee SH, Park JY, et al. Primary incisional therapy with a modified method for patients with benign anastomotic esophageal stricture. Gastrointest Endosc. 2009;69(6):1029–33.

    Article  Google Scholar 

  26. Muto M, Ezoe Y, Yano T, et al. Usefulness of endoscopic radial incision and cutting method for refractory esophagogastric anastomotic stricture (with video). Gastrointest Endosc. 2012;75(5):965–72.

    Article  Google Scholar 

  27. DiSario JA, Pedersen PJ, Bichiş-Canoutas C, et al. Incision of recurrent distal esophageal (Schatzki) ring after dilation. Gastrointest Endosc. 2002;56(2):244–8.

    Article  Google Scholar 

  28. Hordijk ML, Siersema PD, Tilanus HW, et al. Electrocautery therapy for refractory anastomotic strictures of the esophagus. Gastrointest Endosc. 2006;63(1):157–63.

    Article  Google Scholar 

Download references


We thank Mr Fu-Long Zhang for his contribution to the data collection and manuscript editing.


The authors have no source of support or funding to report.

Author information

Authors and Affiliations



YZ conceptualized and designed the study. JX, YS, BW, HW and CH performed the data collection. FZ analyzed and interpreted the data. FZ and JX drafted and critically revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yuandong Zhu.

Ethics declarations

Ethics approval and consent to participate

The study protocol conformed to the ethical guidelines of the Declaration of Helsinki and was approved by the ethics review committee of HangZhou XiXi Hospital (202203022210000201631). Written informed consent was obtained from the patient and from all individual participants included in the study. Neither the transplant donor nor the recipient was from a vulnerable population.

Consent for publication

Written informed consent was obtained from the patient for publication of these cases and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

. The general data of ten paitents.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, F., Xu, J., Zhu, Y. et al. Endoscopic ultrasonography guided cutting scar of esophageal stricture after endoscopic injection sclerotherapy. BMC Gastroenterol 22, 343 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Endoscopic ultrasonography
  • Esophageal stricture
  • Sclerotherapy